Alivpiro Injection
Marketer
Alleviate Pharmaceuticals Pvt. Ltd.
Salt Composition
Piroxicam (40mg)
Overview Alivpiro Injection
Alivpiro Injection provides analgesia for moderate to severe pain, particularly in musculoskeletal conditions. Its use is indicated when oral medication is impractical, offering relief from both pain and inflammation. Administration should always be performed by a healthcare provider; self-injection is strongly discouraged. Dosage and treatment length are determined by individual needs and response, continuing until medically discontinued. Common adverse effects include injection site reactions (pain, redness, swelling), nausea, abdominal discomfort, diarrhea, headache, and vertigo. Persistent or worsening side effects warrant immediate medical attention; management strategies may be available. Prior to treatment, disclose any history of peptic ulcers, cardiovascular disease, hypertension, hepatic or renal impairment, and all current medications, as interactions are possible. This injection is contraindicated during pregnancy and lactation; consultation with a physician is mandatory before use in these circumstances. Prolonged therapy may require regular monitoring of renal and hepatic function, along with blood parameters.
Primary Ingredients of Alivpiro Injection
The provided text is "undefined," therefore no rewriting is possible.
Uses of Alivpiro Injection
Analgesia
Major Benefits of Alivpiro Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Alivpiro Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Stomach pain
- Nausea
- Headache
- Dizziness
How to use Alivpiro Injection:
The medication will be administered by your physician or their qualified staff; self-medication is strongly discouraged.
How Alivpiro Injection works:
Alivpiro Injection is a non-steroidal anti-inflammatory medication that inhibits the production of inflammatory mediators, thus alleviating pain and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use of Alivpiro Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Alivpiro Injection during gestation poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Administering Alivpiro Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Alivpiro Injection can cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving is strongly discouraged if these side effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should use Alivpiro Injection with care; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should receive Alivpiro Injection with close monitoring. The Alivpiro Injection dosage may require modification. Physician consultation is advised.
What if you forget to take Alivpiro Injection :
Should you forget a scheduled Alivpiro Injection, seek your physician's advice.
Facts to Know About Alivpiro Injection
| Label | Value |
|---|---|
| Type of Compound | Compounds derived from enolic acids. |
| Potential for Dependence | None. |
| Type of Treatment | Pain relievers |
FAQs on Alivpiro Injection
Alivpiro Injection and diclofenac are analgesics. Diclofenac, unlike piroxicam (the active ingredient in Alivpiro Injection), exhibits greater selectivity for the COX-2 enzyme, a component of the cyclooxygenase system involved in pain and inflammation. This enhanced selectivity in diclofenac is believed to reduce adverse reactions relative to Alivpiro Injection.
Alivpiro Injection and naproxen are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain perception. Clinical trials indicate comparable efficacy between the two. Naproxen, however, exhibits a lower incidence of gastrointestinal adverse effects relative to Alivpiro Injection.
Alivpiro Injection and meloxicam are analgesics, both non-selectively inhibiting cyclooxygenase—the enzyme mediating inflammation and pain. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam demonstrates a lower incidence of acute gastrointestinal adverse events relative to Alivpiro Injection.
Alivpiro Injection and ketoprofen are both analgesic medications, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate superior efficacy and effectiveness of topical ketoprofen gel relative to Alivpiro Injection. Furthermore, ketoprofen gel demonstrated excellent patient tolerability.
Alivpiro Injection targets cyclooxygenase, an enzyme mediating inflammation and pain, while Tramadol functions as an opioid analgesic. Tramadol carries a risk of dependence.
Alivpiro Injection and nimesulide are analgesics. Alivpiro Injection inhibits cyclooxygenase (COX), an enzyme mediating inflammation and pain, non-selectively, while nimesulide selectively targets COX-2. This selective action of nimesulide is believed to reduce adverse effects relative to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't cause a decrease in platelet count. However, analgesics such as piroxicam may increase bleeding risk. Therefore, avoid taking Alivpiro Injection or other pain relievers for fever accompanied by joint pain. Seek medical advice before commencing Alivpiro Injection treatment.
Alivpiro Injection and aspirin are distinct medications, despite both being classified as COX (cyclooxygenase) inhibitors. Their shared characteristics include anti-inflammatory and analgesic properties.
Concurrent administration of Alivpiro Injection and dexamethasone is contraindicated due to their synergistic toxicity, significantly raising the likelihood of gastrointestinal ulceration.
Concurrent use of methocarbamol and Alivpiro Injection is considered safe, lacking documented significant adverse interactions. However, physician consultation is recommended prior to initiating either treatment.
Paracetamol's concurrent use with Alivpiro Injection is acceptable, as no significant adverse reactions have been reported. Consult your physician prior to initiating either treatment.
Confirmed. Alivpiro Injection is classified as a non-steroidal anti-inflammatory medication.
Alivpiro Injection, a sulfur-based medication, may trigger serious side effects in susceptible patients. These can include severe cutaneous reactions such as Stevens-Johnson syndrome. Always disclose any allergies to your physician.
Alivpiro Injection does not reduce blood clotting; it alleviates pain. Patients with bleeding disorders should not use this medication.
Alivpiro Injection does not relax muscles. It's an analgesic that targets the COX enzyme (cyclooxygenase), which plays a key role in inflammation and pain sensation.
Alivpiro Injection is a non-narcotic analgesic. Its mechanism of action involves inhibiting COX enzymes, thus reducing pain and inflammation.
Alivpiro Injection is unsuitable for managing high blood pressure. Concurrent administration of Alivpiro Injection diminishes the efficacy of antihypertensive drugs. Disclose any antihypertensive medication use to your physician prior to commencing Alivpiro Injection treatment.
Concurrent administration of Alivpiro Injection and losartan is contraindicated. Alivpiro Injection diminishes the efficacy of losartan and similar antihypertensive agents, potentially resulting in inadequate blood pressure control. Disclose any antihypertensive medication use to your physician prior to commencing Alivpiro Injection therapy.
Lisinopril and Alivpiro Injection should not be used concurrently. Concurrent use of piroxicam, a component of Alivpiro Injection, diminishes lisinopril's antihypertensive efficacy, potentially resulting in treatment failure. Patients using antihypertensive drugs must disclose this to their physician prior to Alivpiro Injection administration.
Affirmative. Concurrent administration of Alivpiro Injection and calcium channel blockers is permissible. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) may diminish the efficacy of most antihypertensive medications, with the exception of calcium channel blockers (White, 2007).
Alivpiro Injection is compatible with tizanidine. Piroxicam, an analgesic, and tizanidine, a muscle relaxant, are used together to treat conditions such as back pain.
Affirmative. Alivpiro Injection is compatible with beta-cyclodextrin. Studies indicate that this combination accelerates piroxicam's onset and mitigates gastrointestinal adverse reactions.
Indeed, viable alternatives to Alivpiro Injection exist. Analgesic selection depends on the specific illness. A physician's consultation is necessary before initiating piroxicam therapy or switching medications.
Piroxicam should not be used in patients with allergies to the drug, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores (stomatitis), systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-stage pregnancy, heart conditions, liver dysfunction, or kidney dysfunction.
Alivpiro Injection does not alleviate allergic reactions; it is an analgesic.
Alivpiro Injection provides extended pain relief with a single daily dose. However, individual responses vary, with the analgesic effects of piroxicam generally improving over several weeks of use.
Alivpiro Injection does not induce a euphoric state. It's a non-opioid analgesic.
Alivpiro Injection lacks approval for managing dysmenorrhea. Clinical trials demonstrate piroxicam's notable efficacy in substantially reducing menstrual pain.
Alivpiro Injection lacks regulatory approval for migraine treatment. However, clinical trials indicate its efficacy in substantially reducing migraine pain in patients without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's evaluation to determine the underlying cause of your back pain is necessary before initiating treatment. Avoid self-administering Alivpiro Injection, as the etiology of back pain varies individually.
Indeed, Alivpiro Injection is an appropriate treatment option for acute gout. Clinical trials have demonstrated its considerable efficacy in managing acute gout episodes.
Blood donation is permissible while using Alivpiro Injection. However, it's crucial to disclose your Alivpiro Injection use to your physician prior to donation.
Use of Alivpiro Injection in diabetic individuals requires strict medical supervision due to the potential for prolonged use to induce kidney failure. Since diabetes is a pre-existing risk factor for kidney damage, the addition of piroxicam significantly elevates this risk.
Alivpiro Injection is contraindicated in individuals with impaired kidney function. Prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been linked to kidney damage, including renal papillary necrosis.
Skin reactions, potentially severe and even life-threatening, are a known side effect of Alivpiro Injection. These can include exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). Serious reactions may develop unexpectedly. Report any skin rash, however mild, to your physician and cease Alivpiro Injection immediately.
Alivpiro Injection is contraindicated during pregnancy. Its use is associated with premature ductus arteriosus closure, potentially resulting in fetal cardiac failure and neonatal mortality.
Alivpiro Injection is not suitable for patients with active peptic ulcers due to its potential to induce gastric ulceration and hemorrhage.
Individuals with asthma may exhibit heightened sensitivity to non-steroidal anti-inflammatory medications, such as aspirin, potentially triggering severe asthma episodes. Physician consultation is advised prior to initiating such treatment.
Confirmed. Alivpiro Injection may induce temporary infertility in some cases. Piroxicam's mode of action can potentially hinder or postpone the release of ovarian follicles, a phenomenon linked to reversible infertility in certain patients. Physician consultation is advised prior to commencing treatment.
Alivpiro Injection is contraindicated for concurrent use with diuretics. In certain individuals, Alivpiro Injection diminishes the sodium-excreting action of furosemide and thiazide diuretics. This interaction is believed to result from the suppression of renal prostaglandin production.
The concomitant administration of Alivpiro Injection and lithium is contraindicated. Alivpiro Injection increases plasma lithium concentrations and decreases lithium renal clearance. This effect stems from the nonsteroidal anti-inflammatory drug's (NSAID) inhibition of renal prostaglandin production. Physician consultation is mandatory prior to initiating Alivpiro Injection therapy.
Concurrent use of Alivpiro Injection and warfarin is contraindicated due to a heightened risk of hemorrhage. Patients should disclose warfarin use to their physician before receiving Alivpiro Injection. If administered concomitantly, careful monitoring of the treatment is essential.
Individuals using corticosteroids or anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, tobacco use, and advanced age are additional risk factors for ulcer formation.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin or any nonsteroidal anti-inflammatory drug (NSAID), or who experienced such reactions immediately before or after coronary artery bypass grafting.
Gastrointestinal distress, and in infrequent cases, severe gastrointestinal adverse events including peptic ulcers and hemorrhage, along with severe dermatological reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis, hepatic failure, and kidney injury.
3,018 People bought this recently
Alivpiro Injection
37
MRP 45
17% off